Salbutamol Syrup Recommended Dose
For children weighing ≥15 kg and adults, the recommended dose is 2.5 mg (one vial of 0.083% solution) administered three to four times daily by nebulization, or 4 mg of oral syrup four times daily for children 6-14 years of age. 1, 2
Dosing by Age and Weight
Children Under 2 Years
- Safety established but specific syrup dosing not well-defined in FDA labeling 1
- Historical studies suggest 1-2 mg every 8 hours is safe for children 2-6 years 3
- Inhaled formulations (MDI preferred over nebulizer) are safer than oral in this age group 4
Children 2-6 Years
- Oral syrup: 1-2 mg every 8 hours (three times daily) 5, 3
- This provides effective symptom control with minimal side effects
- The 2 mg dose may cause more tremors and personality changes 5
Children 6-14 Years
- Oral syrup: 4 mg (2 mg/5 mL) four times daily is the preferred dose 2
- The syrup formulation is superior to tablets, with peak effect at 4 hours lasting 6 hours 2
- The 6 mg dose causes more side effects without significantly better efficacy 2
Children Weighing <15 kg (Nebulized)
- Use 0.5% concentration solution instead of 0.083% to allow for doses less than 2.5 mg 1
- Dose not specifically established in FDA labeling for this weight group
Children Weighing ≥15 kg and Adults (Nebulized)
- 2.5 mg (entire 3 mL vial of 0.083% solution) three to four times daily 1
- Delivered over 5-15 minutes via nebulization
- More frequent administration or higher doses are not recommended for routine use 1
Acute Exacerbations (Per Guidelines)
For acute asthma exacerbations, dosing differs significantly from maintenance therapy:
Children (Nebulized)
- 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses 6
- Then 0.15-0.3 mg/kg every 1-4 hours as needed
- For continuous nebulization in critical exacerbations: starting at 10 mg/hour is as effective as 15 mg/hour with shorter treatment duration 7
Adults (Nebulized)
- 2.5-5 mg every 20 minutes for 3 doses 6
- Then 2.5-10 mg every 1-4 hours as needed
MDI Dosing (All Ages)
- 4-8 puffs (90 mcg/puff) every 20 minutes for 3 doses 6
- Then every 1-4 hours as needed
- MDI with valved holding chamber is as effective as nebulized therapy in mild-to-moderate exacerbations 6
Important Clinical Considerations
Common pitfalls to avoid:
- Do not use nebulized salbutamol as first-line in children <2 years—MDI formulation is safer with lower adverse reaction rates 4
- Back-to-back dosing (multiple consecutive doses) provides no additional benefit over single dosing in children who respond initially (FEV1 ≥12% improvement) 8
- Syrup formulation has longer duration of action than tablets in children, making it the preferred oral formulation 2
Expected side effects:
- Tremors are most common (75-85% of patients) 9
- Palpitations occur in approximately 25% with salbutamol 9
- Heart rate increases are expected and statistically significant but rarely clinically concerning 9
- Severe adverse effects requiring treatment discontinuation are extremely rare 4
When to escalate therapy:
- If a previously effective dosage regimen fails to provide usual relief, this signals seriously worsening asthma requiring immediate reassessment 1
- Consider adding ipratropium for severe exacerbations 6
- Oral corticosteroids (1-2 mg/kg/day, maximum 60 mg/day for 3-10 days in children; 40-60 mg/day for 5-10 days in adults) should be added for moderate to severe exacerbations 6, 10